RxDoctor Payments Data

Francisco Candal

Pulmonary Disease · Slidell, LANPI 1851396345

Payments from drug & device makers

$3,640in general payments, 2019–2025

Across 229 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AstraZeneca$696
  • Boehringer Ingelheim$267
  • Grifols USA, LLC$222
  • Insmed, Inc.$135
  • Sunovion Pharmaceuticals Inc.$131
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,624100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,640 in reported general payments places this provider in the 45th percentile of 189 pulmonary disease providers in Louisiana.

See all pulmonary disease providers in Louisiana

Other pulmonary disease in Slidell

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →